ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 156 filers reported holding ACORDA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $333,000 | -92.1% | 9,983 | -92.2% | 0.01% | -91.9% |
| Q1 2015 | $4,236,000 | -90.2% | 127,279 | -87.9% | 0.06% | -89.8% |
| Q4 2014 | $43,090,000 | +140.0% | 1,054,297 | +98.9% | 0.61% | +129.4% |
| Q3 2014 | $17,956,000 | +2037.6% | 530,000 | +1742.7% | 0.26% | +1556.2% |
| Q4 2013 | $840,000 | -23.9% | 28,762 | -10.7% | 0.02% | -36.0% |
| Q3 2013 | $1,104,000 | +118.2% | 32,209 | +110.3% | 0.02% | +108.3% |
| Q2 2013 | $506,000 | – | 15,316 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |